Lupin gets popularity of Betamethasone Dipropionate Ointment USP

Lupin gets popularity of Betamethasone Dipropionate Ointment USP

by admin- Friday, December 20th, 2019 04:13:40 PM

Pharma predominant Lupin has acquired approval for its Betamethasone Dipropionate Ointment USP (Augmented), zero.05%, from america Food and Drug Administration (USFDA), to marketplace a standard equal of Diprolene Ointment, 0.05%, of Merck Sharp and Dohme Corp. The product wi ll be manufactured at Lupin’s Pithampur (Unit 3)
facility, India.

Betamethasone Dipropionate Ointment USP (Augmented), zero.05%, is a corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-respons ive dermatoses in sufferers 13 years of age and older.

News Updates